Checking the Overall Picture for DDR Corp. (DDR)

DDR Corp. (DDR) is an interesting player in the Financial space, with a focus on REIT – Retail. The stock has been active on the tape, currently trading at $7.32, down from yesterday’s close by -3.05%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

DDR Corp. (DDR) currently trades with a market capitalization of $2.80 Billion. That value represents a market adjusting for revenues that have been falling by -9.45 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $320.28 Million over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of $0.03 on a per share basis this quarter. Perhaps, that suggests something about why 20.30% of the outstanding share supply is held by institutional investors.

Technical Analysis

It’s important to check the technicals to get a sense of how DDR has been acting. Looking at the stock’s movement on the chart, DDR Corp. recorded a 52-week high of $13.30. It is now trading 5.98% off that level. The stock is trading $8.01 its 50-day moving average by 0.69%. The stock carved out a 52-week low down at $6.77.

In recent action, DDR Corp. (DDR) has made a move of +1.53% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 16.68, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 4.85% with $293.19 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of DDR.

Previous articleAmicus Therapeutics, Inc. (FOLD): What’s the Story?
Next articleHow Does Celgene Corporation (CELG) Stack Up Right Now?